Indian J Med Microbiol Close
 

Table 4: Immune-related adverse events reported in the included clinical trials of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy

Table 4: Immune-related adverse events reported in the included clinical trials of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy